Follow The Filings

RCUS Arcus Biosciences

Arcus Biosciences earnings company data as of 3:00 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by RCUS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RCUS insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $10.6M sold by 4 insiders under 10b5-1 plans
  1. Alexander Azoy Chief Accounting Officer
    Planned sale
    $85K 2,827 shares at $30.00 6.7% of stake
    Traded Aug 21 Filed Aug 24
    ↗
  2. Juan C. Jaen President
    Planned sale
    $2M 68,569 shares at $29.63 7.7% of stake
    Traded Jul 9–10 Filed Jul 13
    ↗
  3. Juan C. Jaen President
    Planned sale
    $878K 31,431 shares at $27.92 3.4% of stake
    Traded Jun 22–24 Filed Jun 24
    ↗
  4. Alexander Azoy Chief Accounting Officer
    Planned sale
    $66K 2,562 shares at $25.77 6.1% of stake
    Traded Jun 1 Filed Jun 1
    ↗
  5. Robert C. Goeltz II CFO
    Planned sale
    $199K 7,763 shares at $25.63 8.4% of stake
    Traded May 11 Filed May 12
    ↗
  6. Juan C. Jaen President
    Planned sale
    $681K 31,823 shares at $21.41 3.3% of stake
    Traded Jan 5 Filed Jan 7
    ↗
  7. Robert C. Goeltz II CFO
    Planned sale
    $153K 6,552 shares at $23.38 8.8% of stake
    Traded Dec 31, 2025 Filed Jan 2
    ↗
  8. Alexander Azoy Chief Accounting Officer
    Planned sale
    $97K 4,343 shares at $22.25 19% of stake
    Traded Dec 18, 2025 Filed Dec 18, 2025
    ↗
  9. Juan C. Jaen President
    Planned sale
    $2.1M 82,997 shares at $24.71 8% of stake
    Traded Dec 4, 2025 Filed Dec 5, 2025
    ↗
  10. Alexander Azoy Chief Accounting Officer
    Planned sale
    $49K 1,900 shares at $26.00 6.5% of stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
    ↗
  11. Robert C. Goeltz II CFO
    Planned sale
    $125K 5,000 shares at $25.00 5.4% of stake
    Traded Nov 26, 2025 Filed Nov 26, 2025
    ↗
  12. Juan C. Jaen President
    Planned sale
    $1M 50,000 shares at $20.26 4.6% of stake
    Traded Nov 17–18 Filed Nov 19, 2025
    ↗
  13. Jennifer Jarrett COO
    Planned sale
    $954K 50,291 shares at $18.97 19% of stake
    Traded Nov 7, 2025 Filed Nov 12, 2025
    ↗
  14. Juan C. Jaen President
    Planned sale
    $88K 4,314 shares at $20.32 0.4% of stake
    Traded Oct 30, 2025 Filed Nov 3, 2025
    ↗
  15. Juan C. Jaen President
    Planned sale
    $2M 96,859 shares at $20.76 8.2% of stake
    Traded Oct 28–29 Filed Oct 30, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 14 stock grants, 14 sales to cover taxes, 4 option exercises, and 3 gifts.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
424B5 Filing Doc
424B5 Filing Doc
8-K 2.02 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 23 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.